Bayer AG ); German pronunciation: [ˈbaɪ̯ɐ]) is a German multinational, pharmaceutical and life sciences company. It is headquartered in Leverkusen, where its illuminated sign is a landmark. Bayer's primary areas of business include human and veterinary pharmaceuticals; consumer healthcare products; agricultural ...
Bayer Corporation is the American subsidiary of Bayer AG. Its main offices are located in Whippany, New Jersey. In addition it has 40 fully consolidated subsidiary companies located in 19 different states. Contents. [hide]. 1 History. 1.1 Mobay; 1.2 Spin-off. 2 Products; 3 Subsidiaries; 4 Philanthropic activities; 5 See also ...
Bayer invests in differentiated drug pipeline with over 50 projects focused on high unmet medical needs · Press center · Treatment + Care · Cardiovascular and blood disorders · Cancer · Eye conditions · Women's health · Men's health · Other treatment areas · Radiology · Innovation + Partnering · Facts & figures ...
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture.
Bayer HealthCare LLC develops, manufactures, and markets healthcare and medical products. The company offers blood glucose monitoring systems, diabetes self-care software, and lancing devices; and YAZ, a low-dose oral contraceptive. It also provides diagnostic testing for urinalysis, DCA, immunology, blood gas, and ...
Bayer U.S. is a subsidiary of Bayer AG, a global enterprise with core competencies in the fields of healthcare, agriculture and high-tech polymer materials.
Find out more about Bayer Healthcare LLC including an overview, stats, history and other Pharmaceuticals and Biotechnology competitors.
Jul 28, 2017 ... Call, Write or Visit. Bayer Corporation. 100 Bayer Boulevard. Whippany, NJ 07981. 862-404-3000. For all media requests, please reach out to our Media Contacts. Click here to report an adverse event. Click here if you are a US healthcare professional seeking medical information.
More religious-based college employers, and for-profit businesses with moral objections to contraceptive coverage, will be able to issue health plans denying intrauterine device and birth control coverage to their employees and students starting in 2018, under the administration's Oct. 6-issued "conscience rights" ...